Sep 10, 2014

Cantrell Drug Company enhances compounding safety with closed vial filling system from Aseptic Technologies

LITTLE ROCK, Ark. (September 10, 2014) – Cantrell Drug Company today announced it has entered into an exclusive agreement to become the first human drug compounding outsourcing facility to utilize Aseptic Technologies’ closed vial system for aseptic filling of injectable drugs. Outsourcing facilities were created under the federal Drug Quality and Security Act (DQSA) enacted in November 2013.

Under the agreement, Cantrell Drug Company will prepare sterile compounded medications with Aseptic Technologies’ Crystal® Closed Vial Technology, which was designed to increase patient safety by vastly reducing the risk of contamination during the complex filling process used by sterile compounding pharmacies and outsourcing facilities. The new technology simplifies and reduces the risk associated with the glass vial filling process used by pharmaceutical manufacturers. Additionally, it provides easier handling for pharmacists and hospital staff who dispense medication.

“This technology represents a revolutionary advance for Cantrell Drug Company, as well as for the sterile product industry in general,” said Dell McCarley, Chief Executive Officer of Cantrell Drug Company. “We decided to invest in the Crystal Closed Vial Technology because of the high level of quality assurance it will offer to our customers in the hospital market and, by extension, the patients they serve.”

Under the closed vial process, each vial will be assembled in a clean room and sterilized by gamma irradiation before being delivered, ready to fill, to Cantrell Drug Company. A Crystal robotic system in a SKAN isolator fills each vial by piercing the elastic stopper with a special needle, delivering the liquid, and quickly re-sealing the opening with the zap of a laser. Vials are covered with a specially designed cap which health care providers eventually open to withdraw the sterile medication and administer to patients.

Cantrell Drug Company regularly supplies hospitals with sterile compounded medications, some of which are commercially unavailable and others that are simple admixtures. The company is the first U.S. compounding pharmacy to partner with Aseptic Technologies, a Belgium-based business which was spun out of GSK Biologicals, a subsidiary of global pharmaceutical company GlaxoSmithKline, in 2002.

“The collaboration with Cantrell Drug Company is a real opportunity to offer the benefits of the best aseptic technology to a broad base of patients in the United States,” said Aseptic Technologies CEO Patrick Balériaux. “At Aseptic Technologies, we are very proud and excited to actively participate with Cantrell Drug Company in continuing the improvement of drug safety in hospitals thanks to our Crystal Closed Vial Technology and our versatile robotic equipment to be installed in SKAN isolators.”

The Aseptic Technologies partnership continues Cantrell Drug Company’s tradition of innovation and investment to achieve the highest quality standards. Earlier this year, the company was among the first large-scale sterile compounding pharmacies in the nation to register as an outsourcing facility with the U.S. Food and Drug Administration (FDA) and follow more rigorous standards established by the DQSA. Prior to this registration, Cantrell Drug Company had voluntarily listed drug products with the FDA.

“At Cantrell, patient safety is our top priority and that’s why we are always evaluating our operations and seeking opportunities to enhance quality assurance,” said Mike Pierce, President of Cantrell Drug Company. “We believe our investment in the closed vial technology takes us to another level of quality and safety, one that is unsurpassed in the sterile compounding industry.”

About Cantrell Drug Company

Founded in 1952, Cantrell Drug Company is a leading FDA-registered supplier of outsourced pharmacy preparations, specializing in providing custom IV admixtures, epidural preparations, PCA syringes, OR syringes, and drug shortage formulations with the highest quality standards. Cantrell Drug Company provides sterile and non-sterile compounded preparations that meet the needs of patients, physicians, clinics and health care institutions. Based in Little Rock, Ark., Cantrell Drug Company retains state licenses nationwide, a DEA manufacturing license, and an FDA registration.

Read More

Market Buzz

Apr 23, 2018 Lewis Drug Awarded Exemplary Provider® Accreditation
Apr 17, 2018 25% OFF Pharmacy Software License Fee
Apr 04, 2018 TCGRx Announces the Acquisition Of ARxIUM’S Panasonic Fastpak Exp and Fastpak ...
Apr 04, 2018 Fagron Strengthens Strategic Position in USA Through Highly Complementary Acquis...
Mar 30, 2018 KeyCentrix appoints Luis Rodriguez as President
Mar 27, 2018 iMedicare Rebrands to Amplicare, a Decision-Automation Platform that Enables Hea...
Mar 27, 2018 Mercyhealth Adopts Omnicell’s XR2 Automated Central Pharmacy System to Enhance...
Mar 26, 2018 Washington State University Wins 8th Annual Student Pharmacist Compounding Compe...
Mar 26, 2018 H+H SYSTEM, Inc. USA Appoints Marketing Manager
Mar 22, 2018 CVS Health Appoints Derica W. Rice as President of CVS Caremark
Mar 19, 2018 MEDISCA Signs Out-Licensing Agreement with Torrey Hills Technologies for its Pro...
Mar 16, 2018 QS/1® Achieves Level 2 Capability for the Pharmacist Electronic Care Plan
Mar 14, 2018 SuiteRx a Pharmacy Owner's Dream
Mar 13, 2018 Introducing Mission Critical Delivery Solutions as a Thought Leader in Long Term...
Mar 09, 2018 Smith Drug Company Receives the 2018 Distribution Management Award for Cloud-Bas...
Mar 09, 2018 Albertsons Companies Earns URAC Accreditation in Specialty Pharmacy
Mar 06, 2018 Introducing AmerisourceBergen as a Thought Leader & Innovator in Pharmacy: Impro...
Mar 06, 2018 MHA Members WIN BIG with SuiteRx
Mar 02, 2018 Letco Medical, L.L.C. Announces Launch Of Innovative Education Value Program For...
Feb 26, 2018 J M Smith Corporation Announces Leadership Team Changes
Feb 26, 2018 Worz Named New ASCP Executive Director and CEO
Feb 16, 2018 RxSafe Launches Revolutionary Adherence Packaging Automation for Retail Pharmaci...
Feb 15, 2018 Craneware: Significant Contract Wins
Feb 13, 2018 Pomona Valley Hospital Medical Center Adopting In-House IV Compounding with Omni...
Feb 12, 2018 Verity Solutions tops 340B Management Systems Category in 2018 Best in KLAS repo...
Feb 12, 2018 ARxIUM’s RIVA Named Top IV Robot by KLAS for Fifth Consecutive Year
Feb 07, 2018 Multiple Hospitals Adopt Omnicell’s XR2 Automated Central Pharmacy System to E...
Feb 06, 2018 PharmaLink Educates Pharmacy Industry as a Thought Leader in Pharmaceutical Retu...
Feb 05, 2018 Fagron, Inc. Extends Pharmaceutical Ingredient Supply Chain To American Pharmace...
Jan 31, 2018 Letco Med, L.L.C. Announces Partnership with ARL Bio Pharma to Launch Quality Sa...

RXinsider Product Overview Videos